XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 184 filers reported holding XENON PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 2.73 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,121,980 | +218.0% | 91,500 | +258.8% | 1.05% | +251.8% |
| Q2 2023 | $981,750 | +7.6% | 25,500 | 0.0% | 0.30% | +17.3% |
| Q1 2023 | $912,390 | -9.1% | 25,500 | 0.0% | 0.26% | -17.7% |
| Q4 2022 | $1,003,425 | +9.3% | 25,500 | 0.0% | 0.31% | +5.4% |
| Q3 2022 | $918,000 | -96.4% | 25,500 | +3194.6% | 0.29% | +10.5% |
| Q2 2022 | $25,500,000 | +697.4% | 774 | -97.0% | 0.27% | -63.1% |
| Q1 2022 | $3,198,000 | +301.3% | 25,500 | 0.0% | 0.72% | +305.1% |
| Q4 2021 | $797,000 | +105.4% | 25,500 | 0.0% | 0.18% | +89.4% |
| Q3 2021 | $388,000 | -18.1% | 25,500 | 0.0% | 0.09% | -24.8% |
| Q2 2021 | $474,000 | – | 25,500 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ghost Tree Capital, LLC | 850,000 | $15,215,000 | 3.58% |
| ACUTA CAPITAL PARTNERS, LLC | 412,500 | $7,384,000 | 2.66% |
| BVF INC/IL | 3,481,778 | $62,324,000 | 2.34% |
| Soleus Capital Management, L.P. | 708,117 | $12,675,000 | 2.28% |
| COMMODORE CAPITAL LP | 301,392 | $5,395,000 | 2.15% |
| DAFNA Capital Management LLC | 406,535 | $7,277,000 | 1.73% |
| Parkman Healthcare Partners LLC | 374,395 | $6,702,000 | 1.56% |
| Avoro Capital Advisors LLC | 3,650,000 | $65,335,000 | 1.13% |
| KNOTT DAVID M | 144,101 | $2,579,000 | 1.10% |
| Orbimed Advisors | 2,497,917 | $44,713,000 | 0.42% |